AL-amyloidosis in a Female Patient with a Comorbide Pathology: Challenges with Diagnosis
https://doi.org/10.31550/1727-2378-2024-23-1-77-81
Abstract
Aim. To discuses challenges with diagnosis of primary AL-amyloidosis as exemplified by a case study; to analyse the key steps of diagnostic search of systemic amyloidosis in a female patient with a comorbidity.
Key points. In an elderly woman complaining of generalised oedema, shortness of breath, arterial hypertension, at an early stage of diagnostic search, assumptions were made that her oedema was caused by cardiac disorders and that she had congestive heart failure. Given urinary syndrome, azotemia, hypoproteinaemia diagnosed during an initial examination in a district hospital, the patient was referred to the Nephrology Department of the Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, where a comprehensive staged follow-up examination confirmed AL-amyloidosis with kidney, liver, heart involvement.
Conclusion. We have demonstrated challenges with timely diagnosis of systemic amyloidosis as exemplified by a case study in an elderly patient with a comorbidity.
About the Authors
A. N. Maksudov
Kazan State Medical University
Russian Federation
Russian Federation
49 Butlerov St., Kazan, 420012
T. N. Khalfina
Kazan State Medical University
Russian Federation
Russian Federation
49 Butlerov St., Kazan, 420012
G. I. Nurullina
Kazan State Medical University
Russian Federation
Russian Federation
49 Butlerov St., Kazan, 420012
A. F. Khidiyatova
Kazan State Medical University
Russian Federation
Russian Federation
49 Butlerov St., Kazan, 420012
S. M. Levina
Kazan State Medical University
Russian Federation
Russian Federation
49 Butlerov St., Kazan, 420012
G. M. Islamova
Republican Clinical Hospital
Russian Federation
Russian Federation
138 Orenburgsky Highway, Kazan, 420064
References
1. Dima D., Mazzoni S., Anwer F., Khouri J. at al. Diagnostic and treatment strategies for AL amyloidosis in an era of therapeutic innovation. JCO Oncol. Pract. 2023;19(5):265–75. DOI: 10.1200/OP.22.00396
2. Bakulina N.V., Nekrasova A.S., Gudkova A.Ya., Latariya E.L. et al. Systemic amyloidosis: clinical manifestations and diagnosis. Effective Pharmacotherapy. 2020;16(24):68–76. (in Russian). DOI: 10.33978/2307-3586-2020-16-24-68-76
3. Reznik E.V., Nguyen T.L., Stepanova E.A., Ustyuzhanin D.V. et al. Cardiac amyloidosis: internist and cardiologist insight. The Russian Archives of Internal Medicine. 2020;10(6):430–57. (in Russian). DOI: 10.20514/2226-6704-2020-10-6-430-457
4. Quarta C.C., Gonzalez-Lopez E., Gilbertson J.A., Botcher N. et al. Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis. Eur. Heart J. 2017;38(24):1905–8. DOI: 10.1093/eurheartj/ehx047
5. Wisniowski B., Wechalekar A. Confirming the diagnosis of amyloidosis. Acta Haematol. 2020;143(4):312–21. DOI: 10.1159/000508022
6. Riefolo M., Conti M., Longhi S., Fabbrizio B. et al. Amyloidosis: what does pathology offer? The evolving field of tissue biopsy. Front. Cardiovasc. Med. 2022;9:1081098. DOI: 10.3389/fcvm.2022.1081098
7. Hummel K., Meawad H., Gunning W.I.. Gohara A.F. Negative fat pad biopsy in systemic AL: a case report analyzing the preferred amyloidosis screening test. Diseases. 2021;9(2):40. DOI: 10.3390/diseases9020040
8. Garcia Y., Collins A.B., Stone J.R. Abdominal fat pad excisional biopsy for the diagnosis and typing of systemic amyloidosis. Hum. Pathol. 2018:72:71–9. Epub. 2017 Nov. 11. DOI: 10.1016/j.humpath.2017.11.001
9. Al Hamed R., Bazarbachi A.H., Bazarbachi A., Malard F. et al. Comprehensive review of AL amyloidosis: some practical recommendations. Blood Cancer J. 2021;11(5):97. DOI: 10.1038/s41408-021-00486-4
Review
For citations:
Maksudov A.N., Khalfina T.N., Nurullina G.I., Khidiyatova A.F., Levina S.M., Islamova G.M. AL-amyloidosis in a Female Patient with a Comorbide Pathology: Challenges with Diagnosis. Title. 2024;23(1):77-81. (In Russ.) https://doi.org/10.31550/1727-2378-2024-23-1-77-81
Views:
12
Email this article 